Pharmaceuticals

Market 2026 outlook for Ticovac strengthened by formulation innovations and immunization programs

March 27, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Ticovac Market Over The Period 2026–2030?

The ticovac market size has experienced significant expansion in recent years. It is projected to expand from $4.31 million in 2025 to $4.63 million in 2026, achieving a compound annual growth rate (CAGR) of 7.5%. This growth during the historical period was driven by the prevalent existence of tick-borne encephalitis, various public health vaccination programs, increased exposure from outdoor activities, immunization initiatives implemented in hospitals, and regulatory clearances obtained for TBE vaccines.

The ticovac market is projected to experience substantial expansion over the upcoming years, with its size anticipated to reach $6.11 million by 2030, exhibiting a compound annual growth rate (CAGR) of 7.2%. This growth during the forecast period can be attributed to several factors, including the expansion of vaccination coverage across Europe, increased travel to endemic regions, a rise in climate-driven tick populations, more robust preventive healthcare policies, and greater investment in vaccine infrastructure. Major trends expected within the forecast timeframe encompass an escalating demand for tick-borne disease vaccination, the expansion of preventive travel immunization initiatives, an increase in government-sponsored vaccination programs, heightened public awareness of vector-borne illnesses, and enhancements in cold chain distribution for vaccines.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19939&type=smp

What Drivers Are Expected To Influence The Ticovac Market During The Forecast Period?

The increasing occurrence of tick-borne illnesses is anticipated to propel the expansion of the ticovac market in the future. These conditions are ailments passed to people from the bite of ticks carrying infections, originating from bacteria, viruses, or parasites. The increase in tick-borne diseases can be attributed to factors such as shifts in climate, the spread of tick environments, greater human interaction, and improvements in diagnostic methods. Ticovac is essential for combating tick-borne diseases, offering active immunity specifically against tick-borne encephalitis (TBE), a serious viral infection that can be spread by tick bites. For example, data from February 2024, provided by the Centers for Disease Control and Prevention, a US-based government agency, showed that the total incidence of Lyme disease reached 18.9 cases per 100,000 population, marking a rate 68.8% greater than prior years. Within areas with high incidences, the average rate was 58% elevated at 68.3 cases per 100,000, and for children between 5 and 9 years old, the occurrence stood at 16.5 cases per 100,000, representing an 11.5% rise. Consequently, the increased occurrence of tick-borne illnesses is fueling the expansion of the ticovac market.

How Is The Ticovac Market Divided Into Its Major Segments?

The ticovac market covered in this report is segmented –

1) By Formulation: Inactivated Vaccines, Live Attenuated Vaccines

2) By Indication: Tick-Borne Encephalitis, Japanese Encephalitis, Rabies Encephalitis

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

How Are Trends Transforming The Ticovac Market Landscape?

Leading firms within the ticovac market are prioritizing novel formulations, including suspension liquid, to achieve a competitive advantage in the sector. This suspension liquid represents a vaccine formulation developed to prevent tick-borne encephalitis, administered via intramuscular injection. Each dose is 0.5 mL, suitable for both adult and pediatric application. An example of this is Pfizer Inc., a US-based pharmaceutical manufacturer, introducing Ticovac in September 2024; this vaccine targets the prevention of tick-borne encephalitis (TBE), a viral infection impacting the brain and spinal cord. It stands as Japan’s inaugural vaccine of its type, providing defense against the illness in endemic areas. The vaccine comes in two distinct versions, one for adults and another for children, both administered as a 0.5 mL intramuscular injection.

Who Are The Prominent Organizations Shaping The Ticovac Market?

Major companies operating in the ticovac market are Pfizer Inc.

Read the full ticovac market report here:

https://www.thebusinessresearchcompany.com/report/ticovac-global-market-report-

Which Region Is Forecast To Lead The Ticovac Market In Terms Of Market Size?

Europe was the largest region in the ticovac market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the ticovac market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Ticovac Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19939&type=smp

Browse Through More Reports Similar to the Global Ticovac Market 2026, By The Business Research Company

Inductor Market Market Report 2026

https://www.thebusinessresearchcompany.com/report/inductor-market-global-market-report

Train Hvac Market Report 2026

https://www.thebusinessresearchcompany.com/report/train-hvac-global-market-report

Plumbing Heating And Air Conditioning Contractors Market Report 2026

https://www.thebusinessresearchcompany.com/report/plumbing-heating-and-air-conditioning-contractors-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795